HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
Go back to HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.42 +0.03 (7.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.39 | 52 Week High | $31.32 | |||
| Open | $0.40 | 52 Week Low | $13.95 | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $-3.29 | |||
| Volume | 5,463,115 | |||||
